- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Di | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | 434 | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | ||
| Di | Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States | 548 | TORONTO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (TSX Venture: ARCH and OTCQB: ACHFF) today announced that the Company will expand its ongoing Phase II trial of LSALT peptide targeting... ► Artikel lesen | ||
| Di | Subgen AI AB: Subgen AI Group Appoints Fredrik Lundqvist as Chief Financial Officer | 96 | Subgen AI Group announces the appointment of Fredrik Lundqvist as its new Chief Financial Officer (CFO) starting 17 August 2026, succeeding David Jiménez who will step down as CFO for personal matters.... ► Artikel lesen | ||
| Di | Lasernet Group AB (publ) will be delisted, and the last day of trading will be on 24 August 2026 | 101 | Lasernet Group AB (publ) ("Lasernet" or the "Company") has announced through a press release on 30 July 2026 that the Company has applied for delisting of the Company's share from Nasdaq Stockholm.
Nasdaq... ► Artikel lesen | ||
| Di | Eikon Therapeutics, Inc.: Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma | 318 | Selected 0.60 mg/m2 as the single dose for the TeLuRide-006 study going forward for patients randomized to EIK1001 treatment, in accord with a recommendation of the independent Data Monitoring Committee... ► Artikel lesen | ||
| Di | EVgo and GM Enhance the Charging Experience with New Flagship Sites | 713 | WARREN, Mich., Aug. 11, 2026 (GLOBE NEWSWIRE) -- EVgo Inc. (NASDAQ: EVGO) ("EVgo"), one of the nation's largest public fast charging networks today announced the opening of its newest flagship charging... ► Artikel lesen | ||
| Di | Sagimet Biosciences Inc.: Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates | 715 | Phase 3 clinical trial of denifanstat in moderate to severe acne patients for the U.S. on track to initiate in second half of 2026 First-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567... ► Artikel lesen | ||
| Di | Bicara Therapeutics Inc.: Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth | 734 | President & Chief Operating Officer Ryan Cohlhepp, Pharm.D. appointed President & Chief Executive Officer effective January 2027 Claire Mazumdar, Ph.D., MBA to transition to Vice Chair of the Board... ► Artikel lesen | ||
| Di | Intermap Technologies: Intermap Appoints J. Michael Rolland to Board of Directors | 362 | Decades of experience financing strategically important global infrastructure Trusted business builder with a record of growth across public and private markets Former leader at OMERS, one of Canada's... ► Artikel lesen | ||
| Di | Stardust Power Inc.: Stardust Power Appoints Ray Rivers to Board of Directors | 596 | GREENWICH, Conn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Stardust Power Inc. (NASDAQ: SDST) ("Stardust Power" or the "Company"), an American developer of battery-grade lithium carbonate, today announced... ► Artikel lesen | ||
| Di | ZenaTech Inc.: ZenaTech's ZenaDrone Begins In-House PCB Flight Testing, Advancing Vertical Integration Strategy Toward NDAA-Compliant Blue UAS Certification and Expanded Defense Opportunities | 213 | In-house production strengthens ZenaDrone's path to Blue UAS Certification as federal restrictions on Chinese-made drones open a significant market opportunity for compliant American manufacturersVANCOUVER... ► Artikel lesen | ||
| Di | Havila Kystruten AS: Trading Update July 2026 | 133 | Operational Highlights July Occupancy reached 85%, up 3% points from last July. Average Cabin Revenue (ACR) increased by 10% compared to July 2025.Total ticket revenue increased by 13% compared to... ► Artikel lesen | ||
| Di | Xvivo Perfusion AB: XVIVO receives CE certificates for its groundbreaking heart preservation technology, transforming access to life-saving transplants across Europe | 100 | CAUTION-Investigational device in the US. Limited by Federal (United States) law to investigational use. The safety and effectiveness of this device have not been established. The XVIVO heart technology... ► Artikel lesen | ||
| Di | Hub Group, Inc.: Hub Group Files Form 12b-25 and Provides First Half 2026 Business Update | 395 | OAK BROOK, Ill., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Hub Group, Inc. (Nasdaq: HUBG) today announced that it has filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange... ► Artikel lesen | ||
| Di | NeurAxis, Inc.: NeurAxis Reports Record Second Quarter 2026 Financial Results Driven by 116% Year Over Year Revenue Growth | 347 | CARMEL, Ind., Aug. 11, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic... ► Artikel lesen | ||
| Di | FloQast Recognized by Inc. as One of America's Fastest Growing Private Companies for Fourth Consecutive Year | 377 | The company's continued recognition on Inc. 5000 reflects strong customer growth and a vision for the future of accountingNEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FloQast today announced it has been... ► Artikel lesen | ||
| Di | Dark Horse Consulting Group Expands into China, Appoints Kang Liu as Senior Director, Head of China | 426 | WALNUT CREEK, Calif. and SHANGHAI, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (DHCG), a leading life sciences consulting firm specializing in advanced therapies, today announced the... ► Artikel lesen | ||
| Di | Knowit AB: Fredrik Ekerhovd appointed President and CEO of Knowit | 226 | The Board of Directors of Knowit AB has today appointed Fredrik Ekerhovd President and CEO of Knowit AB, effective immediately. Fredrik Ekerhovd has served as Acting President and CEO since August 1... ► Artikel lesen | ||
| Di | etoro Group Ltd.: etoro to Acquire TradeZero to Accelerate US Expansion | 1.296 | NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- etoro Group Ltd. ("etoro", or the "Company") (NASDAQ: ETOR), the trading and investing platform, announced today that it has entered into an agreement to... ► Artikel lesen | ||
| Di | etoro Group Ltd.: etoro Reports Second Quarter 2026 Results | 2.671 | Net Contribution grew by 9% year-over-year to $229 millionFunded accounts grew by 18% year-over-year to 4.28 millionAnnounced agreement to acquire TradeZero NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | ||
| Di | Autolus Therapeutics plc: Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates | 863 | Company reports AUCATZYL® (obecabtagene autoleucel; obe-cel) net product revenue of $45.7 million in Q2 2026, an increase of 119% year-over-yearFY 2026 net product revenue guidance increased to $140... ► Artikel lesen | ||
| Di | Legend Biotech Corporation: Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights | 530 | CARVYKTI (ciltacabtagene autoleucel; cilta-cel) net trade sales increased 50% versus second quarter of 2025 to approximately $657 millionExpanded CARVYKTI availability to 348 global sites and 19 global... ► Artikel lesen | ||
| Di | SUNHYDROGEN, INC.: SunHydrogen Modules Exceed 10% Solar-to-Hydrogen Efficiency in Sparc Hydrogen Testing, Advancing to Pilot Scale | 267 | SunHydrogen's photoelectrochemical and integrated PV-electrolysis modules reached solar-to-hydrogen efficiency above 10% in testing at Sparc Hydrogen's laboratories and produced more hydrogen under... ► Artikel lesen | ||
| Di | BIOXYTRAN, INC.: Bioxytran Reports Encouraging Clinical Observations in First Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patient Treated with PLICID, a Novel Galectin Antagonist Designed with Artificial Intelligence | 157 | Once-weekly intravenous treatment was associated with reported improvements in finger function and walking ability, with no adverse events reported during treatment BOSTON, MA, Aug. 11, 2026 (GLOBE... ► Artikel lesen | ||
| Di | Baker Hughes Awarded Multi-Year Contract by Kuwait Oil Company for Ahmadi Innovation Valley Project | 267 | Agreement positions Baker Hughes as key technology collaborator in KOC's innovation ecosystemTech focus will be on innovative, fit-for-purpose solutions, including digital and AI automation, to address... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.